Columbia Partners Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Columbia Partners Investment Management's BIIB Position: Q2 2018 in Review
Columbia Partners Investment Management sold out of Biogen (BIIB) in Q2 2018, closing a stake of 11,753 shares — an estimated $3.22M sold.
Columbia Partners Investment Management first reported a position in BIIB in Q2 2013 and held it in 20 quarters. The position peaked at $19.4M in Q2 2015. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.
- Columbia Partners Investment Management reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
- Columbia Partners Investment Management sold 11,753 Biogen shares in Q2 2018, an estimated $3.22M.
- Columbia Partners Investment Management first reported a position in Biogen in Q2 2013 and held it in 20 quarters.
- Columbia Partners Investment Management's Biogen position peaked at $19.4M in Q2 2015.
- 1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.
Based on Columbia Partners Investment Management's 13F filing for Q2 2018, filed 12 Jul 2018.